Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis

Laboratory Investigation

Volumn 90, Issue 8, 2010, Pages 1236-1246

  Yamano, Eizo ^a   Miyauchi, Mutsumi ^a   Furusyo, Hisako ^a   Kawazoe, Aki ^a   Ishikado, Atsushi ^b   Makino, Taketoshi ^b   Tanne, Kazuo ^a   Tanaka, Eiji ^c   Takata, Takashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Sunstar Incorporated Company   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

bovine lactoferrin; liposomalization; LPS; osteoclast; proinflammatory cytokines; TNF

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1BETA; LACTOFERRIN; LIPOPOLYSACCHARIDE; LIPOPROTEIN; LIPOPROTEIN RELATED PROTEIN 1; LIPOPROTEIN RELATED PROTEIN 2; LIPOSOMAL BOVINE LACTOFERRIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALVEOLAR BONE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GINGIVA; IMMUNOMODULATION; MALE; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; RAT; UPREGULATION;

ALVEOLAR BONE LOSS; ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CATTLE; COCULTURE TECHNIQUES; CYTOKINES; GINGIVA; INTERLEUKIN-1; LACTOFERRIN; LIPOPOLYSACCHARIDES; MALE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; PERIODONTITIS; RATS; RATS, WISTAR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955130666     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.80     Document Type: Article

References (40)

1. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 1992;63: 322-331.
2. Wilson M, Reddi K, Henderson B. Cytokine-inducing components of periodontopathgenic bacteria. J Periodont Res 1996;31:393-407.
3. Masada MP, Persson R, Kenney JS, et al. Measurement of interleukin-1a and-1b in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J Periodont Res 1990;25:156-163.
4. Reinhardt RA, Masada MP, Kaldahl WB. Gingival fluid IL-1 and IL-6 levels in refractory periodontitis. J Clin Periodontol 1993;20: 225-231.
5. Rossomando EF, Kennedy JE, Hadjimichael J. Tumor necrosis factor-a in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Arch Oral Biol 1990;35:431-434.
6. Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002;8:147-159.
7. Ijuhin N. Light and electron microscopic studies of experimentally- induced pathologic changes in the rat periodontal tissue. Adv Dent Res 1988;2:209-214.
8. Miyauchi M, Takata T, Ito H, et al. Distribution of macrophage lineage cells in rat gingival tissue after topical application of lipopolysaccharide: an immunohistochemical study using monoclonal antibodies: OX6, ED1 and ED2. J Periodont Res 1998;33:345-351.
9. Takata T, Miyauchi M, Ogawa I, et al. Reactive change in proliferative activity of the junctional epithelium after topical application of lipopolysaccharide. J Periodontol 1997;68:531-535.
10. Miyauchi M, Sato S, Kitagawa S, et al. Cytokine expression in rat molar gingival periodontal tissues after topical application of lipopolysaccharide. Histochem Cell Biol 2001;116:57-62.
11. Miyauchi M, Kitagawa S, Hiraoka M, et al. Immunolocalization of CXC chemokine and recruitment of polymorphonuclear leukocytes in the rat molar periodontal tissue after topical application of lipopolysaccharide. Histochem Cell Biol 2004;121:291-297.
12. Brock JH. Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today 1995;16:417-419.
13. Damiens E, Mazurier J, Yazidi I, et al. Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim Biophys Acta 1998;1402:277-287.
14. Choe YH, Lee SW. Effect of lactoferrin on the production of tumor necrosis factor-alpha and nitric oxide. J Cell Biochem 1999;76: 30-36.
15. Haversen L, Ohlsson BG, Hahn-Zoric M, et al. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kB. Cell Immunol 2002;220:83-95.
16. Guillen C, McInnes IB, Vaughan D, et al. The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis. Arthritis Rheum 2000;43: 2073-2080.
17. Hayashida K, Kaneko T, Takeuchi T, et al. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J Vet Med Sci 2004;66:149-154.
18. Wei PF, Ho KY, Ho YP, et al. The investigation of glutathione peroxidase, lactoferrin, myeloperoxidase and interleukin-1beta in gingival crevicular fluid: implications for oxidative stress in human periodontal diseases. J Periodont Res 2004;39:287-293.
19. Troost FJ, Steijns J, Saris WH, et al. Gastric digestion of bovine lactoferrin in vivo in adults. J Nutr 2001;131:2101-2104.
20. Ishikado A, Imanaka H, Kotani M, et al. Liposomal lactoferrin induced significant increase of the interferon-alpha (IFN-alpha) producibility in healthy volunteers. Biofactors 2004;21:69-72.
21. Trif M, Guillen C, Vaughan DM, et al. Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases. Exp Biol Med 2001;226:559-564.
22. Ishikado A, Imanaka H, Takeuchi T, et al. Liposomalization of lactoferrin enhanced it's anti-inflammatory effects via oral administration. Biol Pharm Bull 2005;28:1717-1721.
23. Minkin C, Yu XH. Calcitonin receptor expression and its regulation by 1 alpha-25-dihydroxyvitamin D3 during de novo osteoclast formation in organ cultures of fetal mouse metatarsals. Bone Miner 1991;13:191-200.
24. Cornish J. Lactoferrin promotes bone growth. Biometals 2004;17: 331-335.
25. Lorget F, Clough J, Oliveira M, et al. Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. Biochem Biophys Res Commun 2002;296:261-266.
26. Grey A, Banovic T, Zhu Q, et al. The low-density lipoprotein receptor-related protein-1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol Endocrinol 2004;18:2268-2278.
27. Niemeier A, Kassem M, Toedter K, et al. Expression of LRP1 by human osteoblasts: a mechanism for the delivery of lipoproteins and vitamin K1 to bone. J Bone Miner Res 2005;20:283-293.
28. Cornish J, Callon KE, Naot D, et al. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 2004;145:4366-4374.
29. Elass-Rochard E, Eegrand D, Salmon V, et al. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide- binding protein. Infect Immun 1998;66:486-491.
30. Baveye S, Elass E, Fernig DG, et al. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun 2000;68:6519-6525.
31. Na YJ, Han SB, Kang JS, et al. Lactoferrin works as a new LPS-binding protein in inflammatory activation of macrophages. Int Immunopharmacol 1996;4:1187-1199.
32. Patil C, Rossa Jr C, Kirkwood KL. Actinobacillus actinomycetemcomitans lipopolysaccharide induces interleukin-6 expression through multiple mitogen-activated protein kinase pathways in periodontal ligament fibroblasts. Oral Microbiol Immunol 2006;21:392-398.
33. Hasturk H, Kantarci A, Ohira M, et al. RvE1 protects from local inflammation and osteoclast mediated bone destruction in periodontitis. FASEB J 2005;220:401-403.
34. Takeuchi H, Matsui Y, Yamamoto H, et al. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release 2003;86:235-242.
35. Harada E. Characteristic transfer of colostrum-derived biologically active substances into cerebrospinal fluid via blood in natural suckling neonatal pigs. J Vet Med A 2002;49:358-364.
36. Kuhara T, Yamauchi K, Tamura Y, et al. Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine. J Interferon Cytokine Res 2006;26:489-499.
37. Singh PK. Iron sequestration by human lactoferrin stimulates P. aeruginosa surface motility and blocks biofilm formation. Biometals 2004;17:267-270.
38. Moutsopoulos NM, Madianos P. Low-grade inflammation in chronic infectious diseases. Paradigm of periodontal infection. Ann NY Acad Sci 2006;1088:251-264.
39. Engebretson S, Chertog R, Nichols A, et al. Plasma levels of tumor necrosis factor-a in patients with chronic periodontitis and type 2 diabetes. J Clin Periodontol 2007;34:18-24.
40. Genco RJ, Grossi SG, Ho A, et al. A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol 2005;76:2075-2084.